PAR 2.50% 19.5¢ paradigm biopharmaceuticals limited..

PAR. SP, page-463

  1. 1,665 Posts.
    lightbulb Created with Sketch. 178
    Hotpy, I think most of the pre revenue (especially
    bio) company managements grossly exaggerate
    their prospects of success. When reality sets in,
    the inevitable share price adjustment occurs.
    Every biotech I have as a shareholder is guilty of
    this. In the case of PAR it is mostly about overly
    optimistic timelines, with an eye on the next CR.

    It has been said before, but you can only “cry
    wolf” so many times before people lose trust
    and take what comes out of PR’s mouth as
    very unreliable.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $68.29M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $189.9K 940.0K

Buyers (Bids)

No. Vol. Price($)
5 436602 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 332703 5
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.